The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with chemotherapies and molecular characteristics of HER2-mutant lung cancers.
 
Juliana Eng
No Relationships to Disclose
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Roche
 
Meier Hsu
No Relationships to Disclose
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - Biodesix; Genentech/Roche; Myriad Genetics; Otsuka
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Exelixis; Genentech/Roche; Novartis; Pfizer; Threshold Pharmaceuticals
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)